dc.contributor.author |
GALANDE, SANJEEV |
en_US |
dc.contributor.author |
Mir, Rafeeq |
en_US |
dc.contributor.author |
SHARMA, ANKITA |
en_US |
dc.date.accessioned |
2021-08-27T11:21:37Z |
|
dc.date.available |
2021-08-27T11:21:37Z |
|
dc.date.issued |
2021-09 |
en_US |
dc.identifier.citation |
Frontiers in Genetics, 12, 681063. |
en_US |
dc.identifier.issn |
1664-8021 |
en_US |
dc.identifier.uri |
http://dr.iiserpune.ac.in:8080/xmlui/handle/123456789/6209 |
|
dc.identifier.uri |
https://doi.org/10.3389/fgene.2021.681053 |
en_US |
dc.identifier.uri |
https://www.frontiersin.org/articles/10.3389/fgene.2021.681053/abstract |
en_US |
dc.description.abstract |
Studies over the past four decades have elucidated the role of Wnt/β-catenin mediated regulation in cell proliferation, differentiation and migration. These processes are fundamental to embryonic development, regeneration potential of tissues, as well as cancer initiation and progression. In this review, we focus on the epigenetic players which influence the Wnt/β-catenin pathway via modulation of its components and coordinated regulation of the Wnt target genes. The role played by crosstalk with other signaling pathways mediating tumorigenesis is also elaborated. The Hippo/YAP pathway is particularly emphasised due to its extensive crosstalk via the Wnt destruction complex. Further, we highlight the recent advances in developing potential therapeutic interventions targeting the epigenetic machinery based on the characterization of these regulatory networks for effective treatment of various cancers and also for regenerative therapies. |
en_US |
dc.language.iso |
en |
en_US |
dc.publisher |
Frontiers Media S.A. |
en_US |
dc.subject |
Wnt signaling |
en_US |
dc.subject |
β-catenin |
en_US |
dc.subject |
YAP |
en_US |
dc.subject |
Epigenetics |
en_US |
dc.subject |
Cancer |
en_US |
dc.subject |
Therapeutics |
en_US |
dc.subject |
2021-AUG-WEEK4 |
en_US |
dc.subject |
TOC-AUG-2021 |
en_US |
dc.subject |
2021 |
en_US |
dc.title |
Epigenetic regulation of Wnt/ β-catenin signaling pathway in cancer |
en_US |
dc.type |
Article |
en_US |
dc.contributor.department |
Dept. of Biology |
en_US |
dc.identifier.sourcetitle |
Frontiers in Genetics |
en_US |
dc.publication.originofpublisher |
Foreign |
en_US |